Our Neuroscience Institute strives to provide high-quality, seamless care to patients, their families and our communities. As an example of our commitment, the American Stroke Association set a national improvement target of treating 50% of eligible stroke patients with tPA (tissue plasminogen activator or Alteplase IV r-tPA) within 60 minutes of arriving at an emergency department.
We saw this target as an opportunity to excel. 100% of our hospitals that treat 10 or more stroke patients, over a three month period, have achieved this benchmark.
And, we’ve raised the bar. Our expectation is to treat 75% or more (beyond the national standard of 50%) of eligible stroke patients within 60 minutes.
We will continue to put our patients first and go above and beyond to coordinate care.
See what the National Stroke Association is doing ›